CD40LG and malaria: Here, we assessed IgGand IgM antibody response to α-Gal in patients with patent P. vivaxinfection from Cuiabá, state of Mato Grosso, Brazil (n = 112) (Table), and as controls, malaria-naïve individuals who lived in anon-endemic area and who had never been exposed to malaria (Belo Horizonte, state ofMinas Gerais, Brazil) (n = 20).